Abstract
Fibrinogen, fibrinogen-related antigen (FR-antigen), and components of the fibrinolytic enzyme system were measured in patients with essential hypertension, renal disease with and without hypertension, and normal subjects. Essential hypertension was associated with a decrease in plasminogen activator and an increase in FR-antigen. In renal disease these changes were accompanied by increases in plasminogen activation inhibitor, alpha2-macroglobulin, alpha1-antitrypsin, and fibrinogen.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bennett N. B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):12–22. [PubMed] [Google Scholar]
- Bennett N. B., Ogston D. Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci. 1970 Nov;39(5):549–557. doi: 10.1042/cs0390549. [DOI] [PubMed] [Google Scholar]
- Linton A. L., Gavras H., Gleadle R. I., Hutchison H. E., Lawson D. H., Lever A. F., Macadam R. F., McNicol G. P., Robertson J. I. Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. Lancet. 1969 Jun 28;1(7609):1277–1282. doi: 10.1016/s0140-6736(69)92221-1. [DOI] [PubMed] [Google Scholar]
- MCNICOL G. P., BARAKAT A. A., DOUGLAS A. S. PLASMA FIBRINOLYTIC ACTIVITY IN RENAL DISEASE. Scott Med J. 1965 May;10:189–194. doi: 10.1177/003693306501000502. [DOI] [PubMed] [Google Scholar]
- Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
- Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
- Ogston C. M., Ogston D. Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol. 1966 Jul;19(4):352–356. doi: 10.1136/jcp.19.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prokopowicz J., Worowski K., Poplawski A., Gabryelewicz A., Niewiarowski S. Fibrinolytic system in patients with hypertensive cardiovascular disease. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):1–7. [PubMed] [Google Scholar]
- RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
- SHAINOFF J. R., PAGE I. H. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med. 1962 Nov 1;116:687–707. doi: 10.1084/jem.116.5.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHERRY S., LINDEMEYER R. I., FLETCHER A. P., ALKJAERSIG N. Studies on enhanced fibrinolytic activity in man. J Clin Invest. 1959 May;38(5):810–822. doi: 10.1172/JCI103863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stiehm E. R., Trygstad C. W. Split products of fibrin in human renal disease. Am J Med. 1969 May;46(5):774–786. doi: 10.1016/0002-9343(69)90028-x. [DOI] [PubMed] [Google Scholar]
- VASSALLI P., MCCLUSKEY R. T. THE COAGULATION PROCESS AND GLOMERULAR DISEASE. Am J Med. 1965 Aug;39:179–183. doi: 10.1016/0002-9343(65)90040-9. [DOI] [PubMed] [Google Scholar]
- Wardle E. N., Menon I. S., Rastogi S. P. Study of proteins and fibrinolysis in patients with glomerulonephritis. Br Med J. 1970 May 2;2(5704):260–263. doi: 10.1136/bmj.2.5704.260. [DOI] [PMC free article] [PubMed] [Google Scholar]